G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).

Paolina SalamoneGiuseppe FudaFederico CasaleGiuseppe MarraliChristian LunettaClaudia CaponnettoLetizia MazziniVincenzo La BellaJessica MandrioliIsabella Laura SimoneCristina MogliaAndrea CalvoCorrado TarellaAdriano Chionull null

Published in: BMJ open (2020)

Eudract 2014-002228-28.

Keyphrases

phase ii
double blind
placebo controlled
amyotrophic lateral sclerosis
clinical trial
phase iii
study protocol
open label
squamous cell carcinoma
radiation therapy
smoking cessation
combination therapy